Literature DB >> 10944520

RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.

K Eto1, W Puzon-McLaughlin, D Sheppard, A Sehara-Fujisawa, X P Zhang, Y Takada.   

Abstract

ADAMs (a disintegrin and metalloproteases) mediate several important processes (e.g. tumor necrosis factor-alpha release, fertilization, and myoblast fusion). The ADAM disintegrin domains generally lack RGD motifs, and their receptors are virtually unknown. Here we show that integrin alpha(9)beta(1) specifically interacts with the recombinant ADAMs-12 and -15 disintegrin domains in an RGD-independent manner. We also show that interaction between ADAM-12 or -15 and alpha(9)beta(1) supports cell-cell interaction. Interestingly, the cation requirement and integrin activation status required for alpha(9)beta(1)/ADAM-mediated cell adhesion and cell-cell interaction is similar to those required for known integrin-extracellular matrix interaction. These results are quite different from recent reports that ADAM-2/alpha(6)beta(1) interaction during sperm/egg fusion requires an integrin activation status distinct from that for extracellular matrix interaction. These results suggest that alpha(9)beta(1) may be a major receptor for ADAMs that lack RGD motifs, and that, considering a wide distribution of ADAMs and alpha(9)beta(1), this interaction may be of potential biological and pathological significance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944520     DOI: 10.1074/jbc.M001953200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.

Authors:  Saji Oommen; Shiv K Gupta; Nicholas E Vlahakis
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

2.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro.

Authors:  Gentian Lluri; Garret D Langlois; Paul D Soloway; Diane M Jaworski
Journal:  Exp Cell Res       Date:  2007-06-27       Impact factor: 3.905

3.  Cooperation of the metalloprotease, disintegrin, and cysteine-rich domains of ADAM12 during inhibition of myogenic differentiation.

Authors:  Haiqing Yi; Joanna Gruszczynska-Biegala; Denise Wood; Zhefeng Zhao; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2005-04-23       Impact factor: 5.157

4.  Selective modulation of integrin-mediated cell migration by distinct ADAM family members.

Authors:  Jing Huang; Lance C Bridges; Judith M White
Journal:  Mol Biol Cell       Date:  2005-08-03       Impact factor: 4.138

5.  ADAM-9 (MDC-9/meltrin-gamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin.

Authors:  Abdullah Karadag; Min Zhou; Peter I Croucher
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

Review 6.  Calcium at fertilization and in early development.

Authors:  Michael Whitaker
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

7.  ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.

Authors:  Thomas Tousseyn; Amantha Thathiah; Ellen Jorissen; Tim Raemaekers; Uwe Konietzko; Karina Reiss; Elke Maes; An Snellinx; Lutgarde Serneels; Omar Nyabi; Wim Annaert; Paul Saftig; Dieter Hartmann; Bart De Strooper
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

8.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

9.  Expression of ADAM15 in lung carcinomas.

Authors:  A Schütz; W Härtig; M Wobus; J Grosche; Ch Wittekind; G Aust
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

10.  A disintegrin and metalloproteinase 15 contributes to atherosclerosis by mediating endothelial barrier dysfunction via Src family kinase activity.

Authors:  Chongxiu Sun; Mack H Wu; Eugene S Lee; Sarah Y Yuan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-16       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.